Ascentage Pharma, Bayer AG, Blueprint Medicines Corp., and Bristol Myers Squibb Co. are among the key companies NEW YORK, Jan. 25, 2024 /PRNewswire/ — The gastrointestinal stromal tumors therapeutics market is anticipated to grow by USD 1.02 billion, progressing at a CAGR of 6.01% during…